Revised: 7 November 2019

Information for Healthcare Professionals

This section provides information useful to healthcare professionals.

Medsafe Advice

Date Type Title
21/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #3 – 20 March 2021
14/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #2 – 13 March 2021
13/04/2021CommitteesMedicines Adverse Reactions Committee - Minutes of 185th meeting - 11 March 2021
9/04/2021CommitteesAgenda for the 110th meeting of the Medicines Assessment Advisory Committee - 13 April 2021
7/04/2021Monitoring CommunicationUpdate - Possible risk of psoriasis exacerbation with bupropion
7/04/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #1 – 6 March 2021
29/03/2021ConsultationOutcome of the consultation on the proposed changes to paracetamol warning and advisory statements
23/03/2021Alert CommunicationUPDATE: Concern reported with the use of NovoRapid®Penfill® (insulin aspart; 3 mL cartridge) by type 1 diabetes patients
16/03/2021Alert CommunicationUPDATE - Rocuronium bromide solution for injection 10mg/mL, Hameln, and reports of lack of efficacy
4/03/2021PublicationsPrescriber Update - Vol. 42 No. 1 March 2021
4/03/2021CommitteesAgenda for the 66th meeting of the Medicines Classification Committee
3/03/2021Alert CommunicationYes! Cassette Pregnancy Test Kit (also known as Smith BioMed Rapid Pregnancy Test Kit) - Reports of false positives presenting as faint lines and inconclusive results
3/03/2021COVID-19ICMRA statement for healthcare professionals How COVID-19 vaccines will be regulated for safety and effectiveness

If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.

Show menus
0 1 2 4 5 6 7 9 [ /